About Loxotec
Vienna-based animal health startup behind the Loxovet product line, offering antibacterial care products for dogs and cats based on hypochlorous acid (HOCl), aimed at reducing antibiotic use and improving pet wound and hygiene care.
Vienna, Austria
Read Company ProfileFrequently Asked Questions
What type of funding round did Loxotec raise?
Loxotec raised a unspecified round.
How much did Loxotec raise in its unspecified?
Loxotec raised $200,000 EUR in its unspecified.
When did Loxotec raise its unspecified?
Loxotec raised its unspecified on 2026-03-27.
What was Loxotec's valuation after the unspecified?
Loxotec was valued at $1,000,000 EUR after the unspecified.
Who invested in Loxotec's unspecified?
The investors in Loxotec's unspecified are: Katharina Schneider.
What type of investment was Loxotec's unspecified?
Loxotec's unspecified was a equity investment.
How will Loxotec use the funds from its unspecified?
Loxotec plans to use the funds for: expand into physical retail across Europe, conduct additional veterinary medical studies, develop new product solutions for specific use cases.